Article ID Journal Published Year Pages File Type
6113550 Critical Reviews in Oncology/Hematology 2016 8 Pages PDF
Abstract
This meta-analysis suggests both KRAS and BRAF mutations as poor, prognostic biomarkers, associated with worse survival outcomes, in patients undergoing hepatic resection of CLM.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Hematology
Preview
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis
Authors
, , , , , ,